In vivo gene transfer to sites of inflammatory disease provides a novel met
hod both for studying the effects of cytokines and growth factors, and for
therapeutic intervention. Macrophages play a pivotal role in the developmen
t and control of inflammation and are therefore logical cells to use for ge
netic modification and in vivo gene delivery. In this study we show that ma
crophages (both cell lines and primary cultures) can be transfected by reco
mbinant adenoviruses expressing p-galactosidase, that the macrophages becom
e activated by the transfection process as determined by generation of nitr
ic oxide and can be easily manipulated to localise to inflamed glomeruli af
ter direct injection into the renal artery of rats with an experimentally i
nduced glomerular inflammation caused by nephrotoxic nephritis. The injecti
on of transfected macrophages reduces the severity of injury in this model
of glomerulonephritis as shown by a reduction in the degree of albuminuria.
This approach provides a favourable system for gene delivery in inflammato
ry disease and shows that both the functional properties of the transfected
macrophage as well the transgene if is engineered to produce are relevant
for in vivo gene transfer.